Glenmark Pharmaceuticals informs about media release

12 Oct 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release received from Ichnos Sciences Inc. (wholly owned subsidiary of the Company) regarding Ichnos Sciences Enters Licensing Agreement for OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics.

The above information is a part of company’s filings submitted to BSE.


Glenmark Pharma Share Price

1943.35 9.10 (0.47%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×